Here are relevant reports on : ai-in-clinical-trials-market
-
Cognitive Assessment and Training Market by Component, Organization Size, Application (Clinical Trials, Learning, and Research), Vertical (Healthcare and Life Sciences, Education, and Corporate), and Region - Global Forecast to 2025
The cognitive assessment and training market is projected to reach USD 11.4 billion by 2025, at a CAGR of 29.3% during the forecast period. The cognitive assessment and training vendors have implemented various types of organic as well as inorganic growth strategies, such as new product launches, product upgradations, partnerships and agreements, business expansions, and mergers and acquisitions to strengthen their offerings in the market. The major vendors in the global cognitive assessment and training market include Cambridge Cognition (UK), Cogstate (US), Quest Diagnostics (US), Signant Health (US), Total Brain (US), Pearson (UK), Philips (Netherlands), MedAvante-ProPhase (US), CogniFit (US), ERT (US), VeraSci (US), BrainCheck (US), MeritTrac (India), Berke (US), Neurotrack (US), BrainWare (US), Lumosity (US), The Brain Workshop (UAE), ImPACT Applications (US), Savonix (US), Winterlight Labs (Canada), Aural Analytics (US), Unmind (UK), Kernel (US), and Altoida (US). The study includes an in-depth competitive analysis of these key players in the Cognitive assessment and training market with their company profiles, recent developments, and key market strategies.
- Published: October 2020
- Price: $ 7150
- TOC Available:
-
Wearables in Pharma & Biotech Market by Product (Smartwatches, CGMs, Bands, Rings, Patches, Injectors), Therapy (Diabetes, Cardio, Onco, Mental Health), Application (Drug Discovery, Clinical Trials, Medication Adherence), End User - Global Forecasts to 2031
The global wearables in pharma & biotech market is projected to reach USD 9.97 billion by 2031, growing at a CAGR of 20.2% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Temperature Controlled Pharmaceutical Packaging Market by Type (Primary, Secondary, Tertiary), Packaging Type, Application (Biopharmaceuticals, Vaccines, Clinical Trials, Specialty Pharmaceuticals), End user, and Region - Global Forecast To 2030
The temperature-controlled pharma packaging industry is projected to grow from USD 8.3 billion in 2025 and to reach USD 18.1 billion by 2030, at a CAGR of 17.0% during the forecast period. The key players include Sonoco ThermoSafe (US), Pelican BioThermal (US), Cold Chain Technologies (US), Envirotainer (Sweden), CSafe Global (US), va-Q-tec AG (Germany), SkyCell (Switzerland), Intelsius (UK), Sofrigam (France), and Cryopak (Canada).
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Medical Terminology Software Market Size by Application (Data Aggregation, Reimbursement, Data Integration, Clinical Trials), Products & Services (Services, Platforms), End User (Healthcare Providers, Healthcare Payers, IT Vendors) & Region - Global Forecast to 2027
The size of global medical terminology software market in terms of revenue was estimated to be worth USD 1.0 billion in 2022 and is poised to reach USD 2.5 billion by 2027, growing at a CAGR of 19.3% from 2022 to 2027. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: July 2022
- Price: $ 4950
- TOC Available:
-
AI in Clinical Care Market - Global Forecast 2024 to 2030
Intel Corporation (US), Siemens Healthcare GmbH (Germany), NVIDIA Corporation (US), Medtronic (Ireland), Amazon Web Services, Inc. (US), GE Healthcare (US), Metadvice Ltd. (UK), PathAI (US), Babylon Health (UK), AiCure (US), and Arterys (US) are few key players in the AI in clinical care market globally.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
AI in Clinical Trials Market by Function (Patient Recruitment, Site Optimization, Data Management, Quality, Regulatory), Phase (I, II, III), Indication (Cancer, CNS, CVS), Tool, End-User (Pharma/Biotech, CRO, Hospitals) & Region - Global Forecast to 2030
The global AI in clinical trials market, valued at US$1.20 billion in 2023, stood at US$1.35 billion in 2024 and is projected to advance at a resilient CAGR of 12.4% from 2024 to 2030, culminating in a forecasted valuation of US$2.74 billion by the end of the period. The AI in clinical trials market is experiencing significant growth driven by increasing demand for patient-centred and patient-driven situated trials, where AI improves remote monitoring of patients along with improving retention and recruitment of patients.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Immunotherapy, Pharmacy, Supply Chain), Application (Clinical), End User (Hospitals), Region - Global Forecast to 2030
The global artificial intelligence in healthcare market is projected to reach USD 110.61 billion by 2030, growing at a CAGR of 38.6% during the forecast period (2025–2030). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Europe Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Telehealth, RPM, Immunotherapy, Supply Chain), Application (Clinical), End User (Hospitals) - Forecast to 2030
The Europe Artificial Intelligence (AI) in Healthcare Market, valued at USD 4.20 billion in 2024, stood at USD 6.12 billion in 2025 and is projected to advance at a resilient CAGR of 39.0% from 2025 to 2030, culminating in a forecasted valuation of USD 31.72 billion by the end of the period. This growth is driven by strong regulatory support for digital transformation and the rising adoption of AI-enabled clinical workflows across European health systems.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
US Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Telehealth, Immunotherapy, Pharmacy, Supply Chain), Application (Clinical), End User (Hospitals) - Forecast to 2030
The US artificial intelligence (AI) in healthcare market, valued at US$5.98 billion in 2024, stood at US$8.65 billion in 2025 and is projected to advance at a resilient CAGR of 38.0% from 2025 to 2030, culminating in a forecasted valuation of US$43.30 billion by the end of the period. Market growth is driven by rising demand from providers for automation, nationwide labor shortages, increasing clinical complexity, and strong investment in predictive analytics, imaging AI, and GenAI.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
AI in Life Science Market by Offering (End-to-End, Niche/Point, AI Tech), Application (Drug Discovery, Clinical Trials, Quality Assurance, Regulatory), Tool (Machine Learning, NLP, Computer Vision), End User (Pharma, Biotech) - Global Forecast to 2031
The global AI in life science market is projected to reach USD 69.34 billion by 2031, growing at a CAGR of 26.3% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
